Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

KalVista Pharmaceuticals (KALV) Shares Issued (2018 - 2025)

KalVista Pharmaceuticals' Shares Issued history spans 8 years, with the latest figure at $52.0 million for Q2 2025.

  • On a quarterly basis, Shares Issued rose 173180.0% to $52.0 million in Q2 2025 year-over-year; TTM through Apr 2025 was $55.3 million, a 13456.13% increase, with the full-year FY2025 number at $55.9 million, up 8554.95% from a year prior.
  • Shares Issued hit $52.0 million in Q2 2025 for KalVista Pharmaceuticals, up from $295000.0 in the prior quarter.
  • Over the last five years, Shares Issued for KALV hit a ceiling of $52.0 million in Q2 2025 and a floor of $30000.0 in Q2 2024.
  • Historically, Shares Issued has averaged $9.3 million across 3 years, with a median of $249500.0 in 2023.
  • Biggest five-year swings in Shares Issued: skyrocketed 130.47% in 2024 and later surged 173180.0% in 2025.
  • Tracing KALV's Shares Issued over 3 years: stood at $128000.0 in 2023, then skyrocketed by 130.47% to $295000.0 in 2024, then surged by 17521.69% to $52.0 million in 2025.
  • Business Quant data shows Shares Issued for KALV at $52.0 million in Q2 2025, $295000.0 in Q4 2024, and $3.0 million in Q3 2024.